[go: up one dir, main page]

MX2019012050A - Composicion para usar en el tratamiento de la epilepsia. - Google Patents

Composicion para usar en el tratamiento de la epilepsia.

Info

Publication number
MX2019012050A
MX2019012050A MX2019012050A MX2019012050A MX2019012050A MX 2019012050 A MX2019012050 A MX 2019012050A MX 2019012050 A MX2019012050 A MX 2019012050A MX 2019012050 A MX2019012050 A MX 2019012050A MX 2019012050 A MX2019012050 A MX 2019012050A
Authority
MX
Mexico
Prior art keywords
composition
epilepsy
treatment
epileptic seizures
treating epilepsy
Prior art date
Application number
MX2019012050A
Other languages
English (en)
Other versions
MX395356B (es
Inventor
Matthew Walker
Simon Eaton
Simon Heales
Aziza Khabbush
Maura Louise Odonnell
Patricia Rutherford
Robin- Simon- Brooke Williams
Original Assignee
Vitaflo Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vitaflo Int Ltd filed Critical Vitaflo Int Ltd
Publication of MX2019012050A publication Critical patent/MX2019012050A/es
Publication of MX395356B publication Critical patent/MX395356B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Dairy Products (AREA)

Abstract

Una composición que comprende una relación de ácido decanoico a ácido octanoico de 70:30 A 90:10 p/p para usar en el tratamiento de la epilepsia o en el control de las convulsiones epilépticas.
MX2019012050A 2017-04-10 2018-04-09 Composicion para usar en el tratamiento de la epilepsia. MX395356B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17165690 2017-04-10
PCT/EP2018/059031 WO2018189113A1 (en) 2017-04-10 2018-04-09 Composition for use in the treatment of epilepsy

Publications (2)

Publication Number Publication Date
MX2019012050A true MX2019012050A (es) 2020-08-17
MX395356B MX395356B (es) 2025-03-25

Family

ID=58544776

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019012050A MX395356B (es) 2017-04-10 2018-04-09 Composicion para usar en el tratamiento de la epilepsia.

Country Status (9)

Country Link
US (1) US11351138B2 (es)
EP (1) EP3609489A1 (es)
JP (2) JP7193471B2 (es)
CN (1) CN110678173B (es)
AU (2) AU2018250864B2 (es)
BR (1) BR112019020785A2 (es)
CA (1) CA3058047A1 (es)
MX (1) MX395356B (es)
WO (1) WO2018189113A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7193471B2 (ja) * 2017-04-10 2022-12-20 ヴィタフロ （インターナショナル） リミテッド てんかんの治療に使用するための組成物
WO2021240540A1 (en) 2020-05-26 2021-12-02 Celagenex Research (India) Pvt. Ltd. Novel synergistic nutritional compositions for treating seizures and chronic inflammatory diseases
CN115884766A (zh) * 2020-05-29 2023-03-31 睿升公司 用于使用中链甘油三酯治疗婴儿痉挛的方法
WO2025157899A1 (en) 2024-01-26 2025-07-31 Vitaflo International Ltd Treatment of motor disorders in glucose transporter type 1 deficiency syndrome without inducing ketosis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS591415A (ja) * 1982-06-28 1984-01-06 Mochida Pharmaceut Co Ltd 循環系疾患治療剤
TW248552B (es) * 1993-06-01 1995-06-01 Onoda Yakuhin Kogyo Kk
US6639089B2 (en) * 2000-11-08 2003-10-28 Soda Aromatic Co., Ltd. Anticancer agents, perfumes or foods and drinks
JP5447954B2 (ja) * 2007-09-19 2014-03-19 公益財団法人名古屋産業科学研究所 神経栄養因子様作用剤
WO2010052847A1 (ja) 2008-11-06 2010-05-14 日清オイリオグループ株式会社 濃厚流動食
GB201020133D0 (en) 2010-11-26 2011-01-12 Royal Holloway & Bedford New College Therapeutic use of compounds
GB201210699D0 (en) 2012-06-15 2012-08-01 Vitaflo Ltd Nutritional food
JP7193471B2 (ja) * 2017-04-10 2022-12-20 ヴィタフロ （インターナショナル） リミテッド てんかんの治療に使用するための組成物

Also Published As

Publication number Publication date
BR112019020785A2 (pt) 2020-04-28
RU2019135829A (ru) 2021-05-11
JP2023018063A (ja) 2023-02-07
AU2024202292A1 (en) 2024-06-06
JP7491491B2 (ja) 2024-05-28
CN110678173B (zh) 2023-03-28
CN110678173A (zh) 2020-01-10
MX395356B (es) 2025-03-25
US20200147025A1 (en) 2020-05-14
AU2024202292B2 (en) 2025-05-01
JP2020518557A (ja) 2020-06-25
WO2018189113A1 (en) 2018-10-18
CA3058047A1 (en) 2018-10-18
AU2018250864A1 (en) 2019-10-10
AU2018250864B2 (en) 2024-01-11
EP3609489A1 (en) 2020-02-19
JP7193471B2 (ja) 2022-12-20
RU2019135829A3 (es) 2021-05-26
US11351138B2 (en) 2022-06-07

Similar Documents

Publication Publication Date Title
MX2021008281A (es) Estimuladores de guanilato ciclasa soluble (sgc).
ZA201708692B (en) Antibacterial compounds
JOP20200035A1 (ar) تركيبات حمض أميني لعلاج الإصابات العصبية
SG10201809290SA (en) Compositions and Methods to Treating Hemoglobinopathies
EP4282479A3 (en) Use of pridopidine to treat depression or anxiety
NZ737435A (en) Prodrugs of fumarates and their use in treating various diseases
NZ710444A (en) Compositions and methods for treating neurodegenerative diseases and cardiomyopathy
MY192055A (en) Compounds and compositions for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formation
PH12016501654A1 (en) Diacylglycerol acyltransferase 2 inhibitors for use in the treatment of metabolic and related disorders
PH12019500177A1 (en) Treatment and prevention of sleep disorders
EP4414027A3 (en) Compounds and methods for treating neurological and cardiovascular conditions
MX2017017171A (es) Compuestos terapeuticos y composiciones para el tratamiento de trastornos sociales y trastornos de uso de sustancias.
MX2019012050A (es) Composicion para usar en el tratamiento de la epilepsia.
PH12016500140A1 (en) Heterobicycloaryl rorc2 inhibitors and methods of use thereof
MX379271B (es) Compuestos desestabilizadores de microtubulina para usarse en el tratamiento del cáncer.
UA115128C2 (uk) Протравлювання насіння для боротьби з фітопатогенними грибами
MX2018009662A (es) Metodo y composicion farmaceutica para tratamiento de neurodegeneracion.
WO2015075062A3 (en) Method of treating hair
WO2016134257A8 (en) Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders
PH12022550486B1 (en) Pathogenic control compositions and methods
BR112017007916A2 (pt) compostos sarms para tratamento de distúrbios urológicos
MX2015005733A (es) Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad.
MY192345A (en) Method for producing a deodorizing and antimicrobial agent
IL288307A (en) Preparations for use in the treatment of insulin deficiency conditions
MX2017013669A (es) Composiciones para el tramiento del cancer.